{"DataElement":{"publicId":"3241465","version":"1","preferredName":"FISH Assessment DNA Probe Positive Control Text","preferredDefinition":"The name of the positive control.","longName":"FISH_DNA_P_POS_C_TXT","context":"NCIP","contextVersion":"1","DataElementConcept":{"publicId":"2191353","version":"1","preferredName":"FISH Assessment DNA Probes Identifier","preferredDefinition":"information related to the ID or name of the fluorescence in situ hybridization (FISH) DNA probes  assessment.","longName":"FISH_ASSES_DNAPRO_ID","context":"CTEP","contextVersion":"2.31","ObjectClass":{"publicId":"2660558","version":"1","preferredName":"Fluorescence in situ Hybridization Physical Examination","preferredDefinition":"A type of IN SITU HYBRIDIZATION in which target sequences are stained with fluorescent dye so their location and size can be determined using fluorescence microscopy. This staining is sufficiently distinct that the hybridization signal can be seen both in metaphase spreads and in interphase nuclei.:A physical examination is a systemic evaluation of the body and its functions using visual inspection, palpation, percussion, and auscultation, aimed to determine the presence or absence of physical signs of disease or abnormality for individual's health assessment.","longName":"C17563:C20989","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Fluorescence In Situ Hybridization","conceptCode":"C17563","definition":"A physical mapping approach that uses fluorescent tags to detect hybridization of probes within metaphase chromosomes or less condensed somatic interphase chromatin. This technique can be used for identification of chromosomal abnormalities and for gene mapping.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Physical Examination","conceptCode":"C20989","definition":"A systemic evaluation of the body and its functions using visual inspection, palpation, percussion and auscultation. The purpose is to determine the presence or absence of physical signs of disease or abnormality for an individual's health assessment.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"33E5C497-F487-4C81-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2007-06-27","endDate":null,"createdBy":"SBREXT","dateCreated":"2007-06-27","modifiedBy":"ONEDATA","dateModified":"2007-06-27","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"Property":{"publicId":"2660787","version":"1","preferredName":"DNA Probes Identifier","preferredDefinition":"A piece of DNA that has been labeled, usually radioactively or with a fluorescent dye, which is used in hybridization studies.  Applications include Northern and Southern blots, in situ hybridization techniques, and diagnostic tests.  DNA probes can be highly specific or degenerate.:One or more characters used to identify, name, or characterize the nature, properties, or contents of a thing.","longName":"C451:C25364","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"DNA Probes","conceptCode":"C451","definition":"A piece of DNA that has been labeled, usually radioactively or with a fluorescent dye, which is used in hybridization studies.  Applications include Northern and Southern blots, in situ hybridization techniques, and diagnostic tests.  DNA probes can be highly specific or degenerate.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Identifier","conceptCode":"C25364","definition":"One or more characters used to identify, name, or characterize the nature, properties, or contents of a thing.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"33E73C82-D21B-5882-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2007-06-27","endDate":null,"createdBy":"SBREXT","dateCreated":"2007-06-27","modifiedBy":"ONEDATA","dateModified":"2007-06-27","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ConceptualDomain":{"publicId":"2008551","version":"1","preferredName":"Assessments","preferredDefinition":"evaluations of the patient and the patient's disease.","longName":"ASSESS","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B22DA727-6718-5A2D-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-19","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-19","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"E887A6F7-8286-0FA4-E034-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2004-11-10","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2004-11-10","modifiedBy":"SBR","dateModified":"2016-06-06","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ValueDomain":{"publicId":"3241464","version":"1","preferredName":"Probe Positive Control Text","preferredDefinition":"The name of the positive control.","longName":"PRB_POS_CNTRL_TXT","context":"NCIP","contextVersion":"1","type":"Non-enumerated","dataType":"CHARACTER","minLength":null,"maxLength":"20","minValue":null,"maxValue":null,"decimalPlace":null,"PermissibleValues":[],"ConceptualDomain":{"publicId":"2008557","version":"1","preferredName":"Lab Results","preferredDefinition":"the results of laboratory tests.","longName":"LAB_RESULTS","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B2CFBA7D-D009-7227-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-27","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-27","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"RepresentationTerm":{"publicId":"3241463","version":"1","preferredName":"Probe Positive Control Text","preferredDefinition":"General term for a piece of DNA or RNA corresponding to a gene or sequence of interest, that has been labelled either radioactively or with some other detectable molecule, such as biotin, digoxygenin or fluorescein. As stretches of DNA or RNA with complementary sequences will (hybridize), a probe will label viral plaques, bacterial colonies or bands on a gel that contain the gene of interest. (On-line Medical Dictionary):Involving advantage or good.:The act of directing or determining; regulation or maintenance of a function or action; a relation of constraint of one entity (thing or person or group) by another.:Text; the words of something written.","longName":"C43523:C25246:C61299:C25704","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Probe","conceptCode":"C43523","definition":"General term for a piece of DNA or RNA corresponding to a gene or sequence of interest, that has been labelled either radioactively or with some other detectable molecule, such as biotin, digoxygenin or fluorescein. As stretches of DNA or RNA with complementary sequences will hybridize, a probe will label viral plaques, bacterial colonies or bands on a gel that contain the gene of interest.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"3"},{"longName":"Positive","conceptCode":"C25246","definition":"Involving advantage or good.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"Control","conceptCode":"C61299","definition":"The act of directing or determining; regulation or maintenance of a function or action; a relation of constraint of one entity (thing or person or group) by another.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Text","conceptCode":"C25704","definition":"The words of something written.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"A492BBA0-FB24-FC1E-E040-BB89AD43296D","latestVersionIndicator":"Yes","beginDate":"2011-05-31","endDate":null,"createdBy":"MAESKEB","dateCreated":"2011-05-31","modifiedBy":"ONEDATA","dateModified":"2011-05-31","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"A492BBA0-FB35-FC1E-E040-BB89AD43296D","latestVersionIndicator":"Yes","beginDate":"2011-05-31","endDate":null,"createdBy":"MAESKEB","dateCreated":"2011-05-31","modifiedBy":"MAESKEB","dateModified":"2011-08-25","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ClassificationSchemes":[{"publicId":"2939361","version":"1","longName":"DCTD (Division of Cancer Treatment and Diagnosis)","context":"NCIP","ClassificationSchemeItems":[{"publicId":"3232302","version":"1","longName":"In Situ Hybridization Biomarker Template","context":"NCIP"}]}],"AlternateNames":[],"ReferenceDocuments":[{"name":"Probe Positive Control","type":"Preferred Question Text","description":"Probe Positive Control","url":null,"context":"NCIP"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"A492BBA0-FB4E-FC1E-E040-BB89AD43296D","latestVersionIndicator":"Yes","beginDate":"2011-05-31","endDate":null,"createdBy":"MAESKEB","dateCreated":"2011-05-31","modifiedBy":"MAESKEB","dateModified":"2011-08-25","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"}}